Astria Therapeutics, Inc. (ATXS) has a consensus analyst rating of Hold, based on 8 analysts covering the stock. Of those, 3 recommend buying, 5 recommend holding, and 0 recommend selling.
The analyst consensus price target for ATXS is $22.50, representing a +78.9% upside from the current price of $12.58. Price targets range from a low of $20.00 to a high of $25.00.
